User Fee Level Funding For PDUFA III Set Lower Than Original Bush Budget
Executive Summary
Negotiated PDUFA III user fees reflect a lower budget increase than originally proposed by the Bush Administration
You may also be interested in...
NME Approval Decline Likely To Continue In 2002: Only Two Filed This Year
FDA has received only two NDAs for new molecular entities so far in 2002, Office of New Drugs Director John Jenkins, MD, told UBS Warburg's specialty pharma conference in New York City June 6
NME Approval Decline Likely To Continue In 2002: Only Two Filed This Year
FDA has received only two NDAs for new molecular entities so far in 2002, Office of New Drugs Director John Jenkins, MD, told UBS Warburg's specialty pharma conference in New York City June 6
PDUFA III Funding Level Will Allow Increased Ad Oversight By FDA – HHS
HHS is pointing to the increase in funding under PDUFA III to respond to calls for increased oversight of direct-to-consumer advertising